Research summary ·
Circulating microRNA dysregulation in hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, and dilated cardiomyopathy: a systematic review.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This review looked at microRNAs in the blood of people with heart muscle disease. The diseases were HCM, ACM and DCM. The aim was to see if microRNAs could predict these diseases without invasive tests. The team searched online databases. To avoid false links, it kept only studies with healthy controls and AUC values. 19 papers were used.
What they found
miR-29a-3p was found at higher levels in HCM. miR-185-5p was higher in ACM. miR-454-3p was higher in DCM. These findings came from different studies. The team also checked links between microRNA levels in blood and heart features or genes. No steady pattern showed up across studies.
What it means for patients
The paper says microRNAs were assessed as possible non-invasive markers for these diseases. It says more work is needed before their use in clinics can be judged.
Why it is not certain yet
Studies used different methods. Their patterns did not agree. The paper says larger groups are needed. It also says methods should be consistent. The abstract does not give the number of people. A review can only be as good as the papers in it. Only studies with healthy controls and AUC values were kept.
Source
Circulating microRNA dysregulation in hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, and dilated cardiomyopathy: a systematic review.
PubMed · PMID 42351198We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Dilated cardiomyopathy publications